DexCom (DXCM) Tops Q1 EPS by 9c; offers guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $69.55 +0.69%
Revenue Growth %: +11.2%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +11.2%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q1 EPS of $0.56, $0.09 better than the analyst estimate of $0.47. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.17 billion.
GUIDANCE:
DexCom sees FY2026 revenue of $5.16-5.25 billion, versus the consensus of $5.226 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Starts DexCom (DXCM) at Buy
- Zeta Surgical begins TMS navigation treatments at Hope Therapeutics clinics
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
